Vice President and Regional General Manager of SEA
Suresh Pragasam serves as Vice President and Regional General Manager of Juniper Biologics for its Southeast Asia pharmaceutical operations.
Prior to Juniper, Suresh has 30 years of pharmaceutical experiences across multiple functions, such as sales, marketing, commercial excellence, strategic and business development, and general management with multinational pharmaceutical companies such as GlaxosmithKline, UCB Pharmaceuticals, Sanofi and Mundipharma.
His last position before joining Juniper was as Regional General Manager for Mundipharma for Southeast Asia, Korea, Taiwan, and Hong Kong.
Suresh’s notable successes across Southeast Asia amongst others were maximising post-patent portfolios, new products introduction and launches into new and existing countries, development of Patient Access Programs, integration of newly acquired products, restructuring and turning around of non-profitable companies, Bbuilding and developing people and teams. Suresh was seconded to Brazil and Mexico during his tenure with Sanofi.
Suresh graduated with a Masters in Business Administration from Edith Cowan University, Australia. In addition, Suresh also completed General Management Programs in INSEAD Paris and INSEAD Singapore.
Vice President and Regional General Manager of MEA
Haytham Ramzy serves as Vice President & General Manager, Middle-East & Africa for Juniper Biologics.
Haytham has over 16 years of pharmaceutical experience where he is most recently the Cluster Head in Egypt and Near East. Haytham is a strategic and results-oriented leader with a successful track record in the pharmaceutical industry, partnering CEOs and Boards, leading stakeholder and employee engagement.
As Vice President & General Manager, MEA, Haytham will provide strategic direction to the region’s operations including all sales, marketing, reporting and compliance plans. He will be responsible for establishing Juniper Biologics operations and building long-term partnerships with healthcare professionals, patient groups and government bodies.
He will be an important link between Juniper Biologics and channel partners in the MEA region, and will be accountable for all business development activities, with the aim of growing Juniper Biologics’ business portfolio.
Medical Director
Dr. Ashok Krishna Perumal is a Malaysian registered medical doctor. After completing his compulsory clinical practice, he built a distinguished career with leading multinational companies including MSD (Merck), B. Braun, Fresenius VAMED, Sanofi, and APACMed. Over the years, he has developed broad expertise across pharmaceuticals, medtech, AI and digital health, consulting, and service provider businesses. His core expertise includes medical/scientific affairs, market access, government affairs and public affairs.
He has successfully led and supported strategies that bridge clinical innovation with regulatory, policy, and stakeholder engagement to ensure that patients gain timely access to innovative treatment modalities. He has also designed and delivered educational programs for healthcare professionals that empowers medical communities with evidence-based knowledge and practical tools to improve patient care.
Academically, he graduated from Crimea State Medical University in Ukraine. He also holds an MBA from Open University Malaysia, a Master's in Health Economics from the Barcelona School of Management in Spain, and a Master's in Public Health from Yale University in the United States. In addition, he holds a Southeast Asia Healthcare Leadership Certificate from Harvard Medical School.